Journal list Promote Sponsor
verified SJR 0,836 · Q1 • database Scopus / SJR & Web of Science indexed
Current Urology Reports
United States · Current Science, Inc.
workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access

Current Urology Reports

Current Urology Reports is a journal indexed in SJR in Medicine (miscellaneous) and Urology with an H index of 56. It has a price of 3190 €. It has an SJR impact factor of 0,836 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,836.

Current Urology Reports focuses its scope in these topics and keywords: management, prostate, diagnosis, imaging, pathology, cancer, robotassisted, related, scrotal, modalities, ...

ISSN: 1527-2737
Publisher: Current Science, Inc.
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,836 Q1
H-index 56
Acceptance rate pie_chart
31%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.190 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,836

H-index

56

Docs (year)

40

Docs 3y

167

Total refs

1709

Cites 3y

504

Citable 3y

166

Cites/Doc 2y

2.9

Ref/Doc

42.73

Immediate OA

3190 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer

View more

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?

View more

Female Urethral Diverticulum: Current Diagnosis and Management

View more

Emerging Concepts for Pelvic Organ Prolapse Surgery: What is Cure?

View more

Does the CaverMap device help preserve potency?

View more

Do Circulating Tumor Cells Have a Role in Deciding on Adjuvant Chemotherapy After Radical Cystectomy?

View more

Damage Control Considerations During IPP Surgery

View more

Current Status and Outcomes of Robot-Assisted Laparoscopic Radical Cystectomy and Urinary Diversion

View more

Current management of the adolescent varicocele

View more

Controversies in dealing with small renal masses: How did such a small thing become such a big problem?

View more

Contrast-Enhanced Ultrasound (CEUS): an Excellent Tool in the Follow-up of Small Renal Masses Treated with Cryoablation

View more

Chronic pelvic pain syndrome and the overactive bladder: The inflammatory link

View more
SHOW MORE ARTICLES

Category III chronic prostatitis/chronic pelvic pain syndrome: Insights from the national institutes of health chronic prostatitis collaborative research network studies

View more

A 43-year-old African American man with low-risk prostate cancer

View more

Botulinum toxin treatment for overactive bladder: Risk of urinary retention

View more

Bladder-preserving therapy for muscle-invasive bladder cancer: Should it be recommended to appropriate patients?

View more

Bladder exstrophy in the developing world

View more

Biofeedback Therapy for Dysfunctional Voiding in Children

View more

beta3-Receptor Agonists for Overactive Bladder - New Frontier or More of the Same?

View more

Antibiotic prophylaxis in the management of vesicoureteral reflux

View more

Antibiotic Prophylaxis in Pediatric Urology: An Update

View more

An Appraisal of the Food and Drug Administration Warning on Urogynecologic Surgical Mesh

View more

Advances in Imaging in Prostate and Bladder Cancer

View more

Adipose Tissue-Derived Stem Cells for the Treatment of Erectile Dysfunction

View more

FAQs